Higher levels of serum triglyceride and dietary carbohydrate intake are associated with smaller LDL particle size in healthy Korean women

Oh Yoen Kim; Hye Kyung Chung; Min-Jeong Shin

doi:10.4162/nrp.2012.6.2.120

Journal List > Nutr Res Pract > v.6(2) > 1051201

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kim, Chung, and Shin: Higher levels of serum triglyceride and dietary carbohydrate intake are associated with smaller LDL particle size in healthy Korean women

Original Research

Nutrition Research and Practice

Nutrition Research and Practice 2012; 6(2): 120-125.

Published online: 30 April 2012

DOI: https://doi.org/10.4162/nrp.2012.6.2.120

Higher levels of serum triglyceride and dietary carbohydrate intake are associated with smaller LDL particle size in healthy Korean women

Oh Yoen Kim¹, Hye Kyung Chung^2,³, Min-Jeong Shin²

¹Department of Food Science and Nutrition, Dong-A University, Busan 604-714, Korea.

²Department of Food and Nutrition and Institute of Health Science, Korea University, 145, Anam-ro, Seongbuk-gu, Seoul 136-703, Korea.

³Department of Nutrition Services, Youngdong Severance Hospital, Yonsei University College of Medicine, Seoul 135-720, Korea.

Corresponding Author: Min-Jeong Shin, Tel. 82-2-940-2857, Fax. 82-2-940-2850, mjshin@korea.ac.kr

Received 28 December 2011 Revised 17 January 2012 Accepted 31 January 2012

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The aim of this study was to investigate the influencing factors that characterize low density lipoprotein (LDL) phenotype and the levels of LDL particle size in healthy Korean women. In 57 healthy Korean women (mean age, 57.4 ± 13.1 yrs), anthropometric and biochemical parameters such as lipid profiles and LDL particle size were measured. Dietary intake was estimated by a developed semi-quantitative food frequency questionnaire. The study subjects were divided into two groups: LDL phenotype A (mean size: 269.7Å, n = 44) and LDL phenotype B (mean size: 248.2Å, n = 13). Basic characteristics were not significantly different between the two groups. The phenotype B group had a higher body mass index, higher serum levels of triglyceride, total-cholesterol, LDL-cholesterol, apolipoprotein (apo)B, and apoCIII but lower levels of high density lipoprotein (HDL)-cholesterol and LDL particle size than those of the phenotype A group. LDL particle size was negatively correlated with serum levels of triglyceride (r = -0.732, P < 0.001), total-cholesterol, apoB, and apoCIII, as well as carbohydrate intake (%En) and positively correlated with serum levels of HDL-cholesterol and ApoA1 and fat intake (%En). A stepwise multiple linear regression analysis revealed that carbohydrate intake (%En) and serum triglyceride levels were the primary factors influencing LDL particle size (P < 0.001, R² = 0.577). This result confirmed that LDL particle size was closely correlated with circulating triglycerides and demonstrated that particle size is significantly associated with dietary carbohydrate in Korean women.

Keywords: LDL particle size, dietary carbohydrate, LDL phenotype, triglyceride

Introduction

A report from the Korea National Statistical office shows that cardiovascular disease (CVD) remains the leading killer, illustrating the continued burden of mortality arising from CVD. Mortality rate from CVD including cerebrovascular disease has been > 20% since 1983 and ranks next to cancer [1]. Thus, an effort has been made to identify potential mechanisms to explain the cardiovascular risks even in treated individuals.

In particular, one of the unfavorable features of CVD risk in Koreans is that hypertriglyceridemia concomitant with low high density lipoprotein (HDL)-cholesterol is very widely prevalent [2]. Additionally, the prevalence of metabolic syndrome (MetS) is high even in patients with a relatively lower body mass index (BMI) [3]. Finally, small dense low density lipoprotein (LDL) (sd-LDL) concentrations are higher in Koreans compared with those in Scots [4]. This raises the possibility that sd-LDL could be an independent risk factor for CVD through its metabolic associations with triglycerides (TG) and the presence of MetS particularly in Koreans whose LDL cholesterol levels are relatively lower than those of western societies [5].

The plasma lipoprotein profile accompanying a predominance of sd-LDL particles (phenotype B) is associated with an increased risk for CVD, as evidenced by case control studies of myocardial infarction [6-7] and angiographically documented coronary artery disease [8]. Some prospective studies also show the relationship between peak LDL particle size and CVD development [9-10].

Despite the high predominance of sd-LDL in Koreans, identifying factors responsible for high plasma levels of sd-LDL has not been studied. Therefore, this study investigated the factors that characterize the LDL phenotype and LDL particle size levels in healthy Korean women. We first compared features, including serum lipids, plasma LDL particle size, and dietary components between LDL phenotypes A and B to determine the factors influencing the levels of LDL particle size in healthy Korean women.

Subjects and Methods

Study subjects

Fifty-seven healthy women (mean age, 57.4 ± 13.1 yrs; range, 33-85 yrs) were included in the analysis. The subjects were all healthy non-smokers. Those who were taking hypolipidemic medications, hormone replacement therapy, or had been diagnosed with uncontrolled hypertension or type 2 diabetes mellitus were excluded. At the start of the study, we examined life style habits of each participant i.e., yes or no to regular exercise, cigarette smoking, alcohol consumption and dietary supplementation such as antioxidative vitamins and isoflavone, which could influence the variables studied. The purpose of this study was carefully explained to all participants, and their informed consent was obtained prior to participation. This study protocol was approved by the Institutional Review Board of Yonsei University College of Medicine and carried out in accordance with the Declaration of Helsinki.

Anthropometric parameters and blood collection

Body weight and height of the subjects were measured, and body mass index (BMI) was calculated. Venous blood samples were collected from the forearm into EDTA-treated (plasma for LDL particle size) and plain (serum for other lipid profiles and fasting glucose) tubes after fasting. The tubes were immediately covered with aluminum foil and placed on ice until they arrived at the analytical laboratory. The blood samples were centrifuged to yield plasma or serum, and stored at -70℃ until analysis.

Dietary survey

We acquired dietary data using a semi-quantitative food frequency questionnaire (SFFQ), as described by Suh et al. [11] and Nam et al. [12]. Briefly, the SFFQ contains 87 food items generally consumed daily by Koreans. Several food categories were included, for example, rices and their products (i.e., white rice, whole grains cooked or uncooked formed), noodles such as cold noodles, hot noodles, instant noodles, and ramen, bread and pains, cereals and their products, potatoes and starches, simple sugars, vegetables, and fruits. Each subject was asked to report their usual frequency of consumption and their usual portion size during the past year. During the interview, food models and reference utensils were shown to subjects to help them estimate portion size. The frequency of consumption was measured on a nine-point scale: never, 1 time/month, 2 times/month, 1 time/wk, 3 times/wk, 5 times/wk, 1 time/day, 2 times/day, and 3 times/day. The questionnaire was used for mixed dish recipes. Intake was assessed on four scales: one-half, one, one and a half, and a double portion size. Nutrient intake was calculated using Korean food composition tables and other published data [13-14].

Serum lipid profiles and glucose concentrations

Serum cholesterol, LDL-cholesterol, and HDL-cholesterol were measured with commercially available enzymatic kits (Choongwae, Seoul, Korea). Serum triglyceride levels were analyzed using a total glycerol test kit (Roche, Basel, Switzerland). All measurements were conducted on a Hitachi 747 auto-analyzer (Hitachi Ltd. Tokyo, Japan). Apolipoproteins AI (apoAI) and B (apoB) were measured by immunoturbidometric assay (Express 550 Plus analyzer). Total apolipoprotein CIII (apoCIII), one of the major apolipoproteins found in TG-rich particles, was measured in triplicate by sandwich assay (International Immunology Corp., Murrieta, CA, USA). Fasting serum glucose concentrations were measured using the glucose oxidase method with a Beckman Glucose Analyzer (Beckman Instruments, Irvine, CA, USA).

Plasma LDL particle size and determining LDL phenotype

Non-denaturing polyacrylamide gradient gel electrophoresis with lipid staining of the plasma was performed to determine peak LDL particle diameter, as described previously [15]. Briefly, electrophoresis was performed on whole plasma and on the plasma fraction with density < 1.063 kg/L (prepared by ultracentrifugation) using Pharmacia PAA 2/16% gradient gels (Uppsala, Sweden). Stained gels were scanned with a Transidyne RFT scanning densitometer (Ann Arbor, MI, USA), and peak particle diameters of the major LDL subclasses were calculated from calibration curves using standards of known size. A smaller LDL peak diameter indicated a relative abundance of sd-LDL particles. Subjects were grouped on the basis of two modes; one grouping comprised subjects with buoyant-mode profiles (peak LDL particle diameter ≥ 256 Å including large LDL subclass pattern: ≥ 264 Å, and intermediate LDL subclass pattern: 256 Å ≤ peak LDL particle diameter ≤ 263 Å) designated phenotype A, and the other subjects with dense-mode profiles (peak LDL particle diameter ≤ 255 Å), were designated phenotype B [16].

Statistical analysis

The SPSS 12.0 software package was used for statistical analysis (SPSS, Inc. Chicago, IL, USA). We used Pearson's correlation coefficient to evaluate the relationships among variables and stepwise multiple regression analyses to identify factors influencing LDL particle size levels. Data are presented as means ± standard deviations. Each variable was examined for normality, and abnormally distributed variables were log-transformed. Differences in the values between phenotypes A and B were evaluated using Student's t-test or the Mann-Whitney U-test (nonparametric t-test). P-values < 0.05 were considered statistically significant.

Results

Comparisons of baseline characteristics between phenotypes A and B

Baseline characteristics of the 57 healthy, non-smoking women are shown in Table 1. Subjects were grouped as LDL phenotype A (mean size, 269.7 Å; range, 257.34-294.63, n = 44) or LDL phenotype B (mean size, 248.2 Å; range, 219.4-254.57, n = 13) (Fig. 1.). As shown in Table 1, age and the proportions of subjects who exercised, consumed alcohol, and were postmenopausal were similar between the two groups. Mean BMIs were significantly higher in the subjects with LDL phenotype B than those with LDL phenotype A. As expected, the subjects with phenotype B showed significantly higher levels of serum TG (P < 0.001), total cholesterol (P < 0.001), LDL-cholesterol (P < 0.05), apoB (P < 0.001), and apoCIII (P < 0.005) but significantly lower levels of HDL-cholesterol (P < 0.001). The concentrations of apoAI and fasting glucose were not different between the two groups.

Comparisons of energy and nutrient intakes between phenotypes A and B

Table 2 shows the estimated energy and nutrient intakes between the two groups. The percentage of carbohydrates as total energy intake [carbohydrate (% En)] was significantly higher in subjects with LDL phenotype B than those with LDL phenotype A (P < 0.05), whereas the percentage of fat for total energy intake [fat (% En)] was significantly lower in the subjects with LDL phenotype B than those with LDL phenotype A (P < 0.05). Retinol intake was greater in the subjects with LDL phenotype B than those with LDL phenotype A (P < 0.01). No significant differences were observed in other nutrient intakes between the two groups.

Associations between LDL particle size and selected macronutrient intake and biochemical measurements

We evaluated the associations between the levels of LDL particle size with selected biochemical measurements (TG, total cholesterol, LDL cholesterol, HDL cholesterol, and apo AI, B, and CIII) and macronutrient intake [% En, percent of energy intake from carbohydrate, fat and protein], which were significantly different between the two groups (Table 3). The results showed that LDL particle size levels were negatively correlated with TG, total cholesterol, apoB, and apoCIII. The LDL particle size levels were positively correlated with HDL cholesterol and apoAI. As LDL particle size was highly associated with TG, the parameters were adjusted for TG. When adjusted for plasma TG, the significant correlations between LDL particle size and total cholesterol, LDL cholesterol, and apoAI, B, and CIII disappeared. A weak relationship was observed between LDL particle size and HDL cholesterol after adjusting for TG (P = 0.058). LDL particle levels were negatively associated with carbohydrate (%) intake (P < 0.005) and positively associated with fat (%) intake (P < 0.005). These correlations remained significant after adjusting for TG (P < 0.05 for both). Additionally, we identified factors influencing LDL particle size levels using a stepwise multiple regression analysis. Baseline characteristics (i.e., age, BMI, menopause, exercise, alcohol consumption), lipid profiles (i.e., TG, HDL-cholesterol and apolipoproteins) and macronutrient intake [carbohydrate (%) and fat (%)] were used as independent variables in the model. Among the input variables, we included lipid profiles and macronutrient intake, which were significantly different between the LDL phenotype groups and also significantly correlated with LDL particle size after adjusting for TG. This model revealed that serum levels of TG (P < 0.001) and carbohydrate (%) intake (P < 0.05) were closely associated with LDL particle size levels (Table 4).

Discussion

The aim of this study was to investigate the major factors that characterize the LDL phenotypes and the levels of LDL particle size, a potential risk factor for CVD and related diseases, in healthy Korean women. The present results confirmed that LDL particle size (LDL phenotype) was closely correlated with circulating TG levels and demonstrated, for the first time, that LDL particle size was significantly associated with dietary carbohydrate intake in Korean women.

Many studies have reported that sd-LDL, LDL III, or the LDL phenotype B are associated with elevated circulating TG levels, abdominal adiposity, increased concentrations of apolipoprotein B, and decreased concentrations of HDL-cholesterol [7,8,17]. In addition, sd-LDL has been postulated to be a major risk factor for CVD [7]. According to a report by Austin et al. [6], subjects with a LDL profile dominated by sd-LDL have a three-fold increased CVD risk. Griffin et al. [8] also reported a seven-fold increase in CVD risk for sd-LDL concentrations > 100 mg/dl. Several physiological mechanisms have been attributed to the greater atherogenicity of dense than buoyant LDL [18-20]. sd-LDLs are taken up less readily by LDL receptors, penetrate more readily into arterial tissue, bind more tightly to arterial proteoglycans, and are oxidized more rapidly than larger LDL particles [18-20].

sd-LDL prevalence in Asian Indians is significantly higher than that in Caucasians [21]. Cho et al. [4] also reported that both male and female Koreans have higher relative proportions of LDL III compared to those in Scots. The elevated level of sd-LDL might be due to differences in genetics or environmental factors such as dietary habits among ethnic groups. Additionally, several studies have confirmed that the predominance of sd-LDL is also significantly influenced by specific genes related to lipid metabolism, including the cholesteryl ester transfer protein, the LDL receptor, manganese superoxide dismutase, lipoprotein lipase, APOE, and APOA5 [22] In the present study, the regression analysis revealed that serum levels of TG and dietary carbohydrate intake were independent factors for LDL particle size, which is supported by previous reports [21,22]. It is well known that circulating TG is strongly associated with LDL particle size and density [22]. There is also evidence that LDL III concentration increases linearly through the whole range of circulating TG concentration in Korean men, whereas in Scottish men, there was a threshold of 108 mg/dl triglyceride above which there was a positive association [4], suggesting that circulating TG may interact with certain dietary patterns (i.e., high or low carbohydrate intake) and/or with genetic backgrounds (Asians or Caucasians) to form sd-LDLs. LDL particle size was also correlated with circulating levels of HDL-cholesterol, apoB, apoAI, and apoCIII. However, these associations were no longer significant after adjusting for serum TG levels, suggesting that they were mediated through metabolic associations with high levels of circulating TG. In contrast, numerous studies have investigated the association between dietary macronutrient proportions and lipid profiles, particularly the effects of alterations in dietary carbohydrate on fasting blood TG concentrations in postmenopausal women [23-25]. The increased carbohydrate intake observed in this study may cause the synthesis of free fatty acids in the liver, which, in turn, could potentially stimulate the production of large TG-rich very low density lipoprotein, a precursor of sd-LDL particles [26]. Despite rapid transitions in dietary patterns over time in Korea [27], dietary carbohydrates are still the major source of energy intake in Korea. Thus, it is possible that high carbohydrate intake is somehow related to the expression of these phenotypes through its metabolic associations.

We focused on female subjects in this study because dyslipidemia characterized by lower HDL cholesterol, smaller LDL cholesterol particle size, and higher TG is a strong contributing factor to the increased CVD risk, which is more remarkable in females than males [28]. The influence of MetS on the increased risk for CVD is greater among women than among men [29,30]. Particularly, pregnancy, lactation, gestational diabetes mellitus, preeclampsia, polycystic ovary syndrome, hormonal contraceptives, and menopause are considered factors influencing MetS and CVD risk together with central adiposity, dyslipidemia, hypertension, and hyperglycemia in women [31]. In addition, a study conducted in Koreans [32] reported that abdominal obesity is significantly related to carbohydrate intake in women but not in men. Furthermore, the Korean National Health and Nutrition Examination Survey reported that subjects with MetS consume a higher percentage of energy from carbohydrates than those without MetS, which was remarkable in women [33]. Therefore, special dietary efforts emphasizing the limitation of high carbohydrate intake for Korean women would improve the increasing burden of CVD risk. Krauss [22,34] showed a strong linear relationship between decreased fat/increased carbohydrate intake and the prevalence of the LDL subclass pattern B in healthy men, indicating that the prevalence of pattern B in men consuming 30% fat is ~30-35%, which corresponds to the consumption of > 55% carbohydrate [22,34]. Taken together, the cut-off point for carbohydrate intake in Koreans to maintain a healthy LDL phenotype needs to be established, as Koreans consume a relatively higher percentage of energy from carbohydrates compared to that of Western people, although the effect of ethnicity still must be considered.

This study had several limitations. It was a cross-sectional study and had a small sample size. Additionally, information such as glycemic index needs to be included to address the associations more precisely. Nevertheless, the present study was meaningful because it was conducted in a very homogenous group of Koreans. In summary, the present study showed that LDL particle size (LDL phenotype) was closely correlated with circulating TG levels and demonstrated, for the first time, that particle size is significantly associated with dietary carbohydrate intake in Korean women.

Figures and Tables

Fig. 1

Distribution of low-density lipoprotein (LDL) particle size in all study subjects (LDL phenotypes A and B). LDL phenotype A group (mean size: 269.7 Å, n = 44), subjects with buoyant-mode profiles [peak LDL particle diameter ≥ 264 Å] including intermediate LDL subclass pattern [256 Å≤ peak LDL particle diameter ≤ 263 Å]; LDL phenotype B group (mean size: 248.2 Å, n = 13), subjects with dense-mode profiles [peak LDL particle diameter ≤ 255 Å]

Table 1

Comparisons of baseline characteristics between phenotypes A and B

Mean ± SD.

^*P < 0.05, ^**P < 0.01, ^***P < 0.001: P-values < 0.05 indicate significant differences in the variables between the two groups (phenotype A vs. phenotype B), which were evaluated by Student's t-test or the Mann-Whitney U-test.

¹⁾alcohol use, exercise and postmenopause were expressed as numbers and % of subjects who answered positively to these questions (n, %: yes).

BMI, body mass index; NS, not significant

Table 2

Comparisons of energy and nutrient intakes between phenotypes A and B

Mean ± SD.

^*P < 0.05, ^**P < 0.01: P-values < 0.05 indicate statistically significant differences in the variables between the two groups (phenotype A vs. phenotype B), which were evaluated by Student's t-test or the Mann-Whitney U-test.

Carbohydrate (%En), protein (%En), and fat (%En): percent of energy intake for dietary carbohydrate, protein, and fat, respectively.

Table 3

Correlations between low-density lipoprotein (LDL) particle size and selected macronutrient intakes and biochemical measurements

Tested by Pearson's correlation (r₀) or partial correlation (r₁) analysis

r₀, unadjusted correlation coefficient; r₁, correlation coefficient adjusted by serum triglycerides

^*P < 0.05, ^**P < 0.01, ^***P < 0.001: P-values < 0.05 indicate statistical significance. Carbohydrate (%En), protein (%En), and fat (%En): percent of energy intake from dietary carbohydrate, protein, and fat, respectively.

Table 4

Stepwise multiple regression analysis to identify factors influencing low-density lipoprotein (LDL) particle size levels

Independent variables in the regression models, included baseline characteristics (i.e., age, BMI, menopause, exercise, alcohol consumption), lipid profiles (i.e., TG, HDL-cholesterol, and apolipoproteins) and macronutrient intake [carbohydrate (%En) and fat (%En)].

Carbohydrate (%En) and fat (%En): percent of energy intake from dietary carbohydrate and fat, respectively

References

1. Statistics Korea. Summary Report of the Cause of Death Statistics. 2010. Daejeon: Statistics Korea.

2. Sung KC, Kim SH, Reaven GM. Relationship among alcohol, body weight, and cardiovascular risk factors in 27,030 Korean men. Diabetes Care. 2007. 30:2690–2694.

3. Hyun YJ, Kim OY, Jang Y, Ha JW, Chae JS, Kim JY, Yeo HY, Paik JK, Lee JH. Evaluation of metabolic syndrome risk in Korean premenopausal women: not waist circumference but visceral fat. Circ J. 2008. 72:1308–1315.

4. Cho HK, Shin G, Ryu SK, Jang Y, Day SP, Stewart G, Packard CJ, Shepherd J, Caslake MJ. Regulation of small dense LDL concentration in Korean and Scottish men and women. Atherosclerosis. 2002. 164:187–193.

5. Chun S, Min WK, Park H, Song J, Kim JQ, Min YI, Kim SR, Lee SH. The risk groups for coronary heart disease in Koreans. Assessment by distribution of serum lipid concentrations. Clin Chem Lab Med. 1999. 37:969–974.

6. Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation. 1990. 82:495–506.

7. Austin MA, Rodriguez BL, McKnight B, McNeely MJ, Edwards KL, Curb JD, Sharp DS. Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men. Am J Cardiol. 2000. 86:412–416.

8. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis. 1994. 106:241–253.

9. Stan S, Levy E, Delvin EE, Hanley JA, Lamarche B, O'Loughlin J, Paradis G, Lambert M. Distribution of LDL particle size in a population-based sample of children and adolescents and relationship with other cardiovascular risk factors. Clin Chem. 2005. 51:1192–1200.

10. Shin MJ, Krauss RM. Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men. Atherosclerosis. 2010. 211:337–341.

11. Suh I, Oh KW, Lee KH, Psaty BM, Nam CM, Kim SI, Kang HG, Cho SY, Shim WH. Moderate dietary fat consumption as a risk factor for ischemic heart disease in a population with a low fat intake: a case-control study in Korean men. Am J Clin Nutr. 2001. 73:722–727.

12. Nam CM, Oh KW, Lee KH, Jee SH, Cho SY, Shim WH, Suh I. Vitamin C intake and risk of ischemic heart disease in a population with a high prevalence of smoking. J Am Coll Nutr. 2003. 22:372–378.

13. Lee YC, Lee HJ, Oh KW. Fatty Acid Composition of Korean Foods. 1995. Seoul: Shin Kwang Publisher.

14. Ministry of Health and Welfare. Korean Food Composition Table. 1996. Seoul: Ministry of Health and Welfare.

15. Dreon DM, Fernstrom HA, Williams PT, Krauss RM. Reduced LDL particle size in children consuming a very-low-fat diet is related to parental LDL-subclass patterns. Am J Clin Nutr. 2000. 71:1611–1616.

16. Krauss RM, Dreon DM. Low-density-lipoprotein subclasses and response to a low-fat diet in healthy men. Am J Clin Nutr. 1995. 62:478S–487S.

17. Lamarche B, Tchernof A, Mauriège P, Cantin B, Dagenais GR, Lupien PJ, Després JP. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA. 1998. 279:1955–1961.

18. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res. 1982. 23:97–104.

19. Berneis KK, Krauss RM. Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res. 2002. 43:1363–1379.

20. Anber V, Millar JS, McConnell M, Shepherd J, Packard CJ. Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans. Arterioscler Thromb Vasc Biol. 1997. 17:2507–2514.

21. Kulkarni KR, Markovitz JH, Nanda NC, Segrest JP. Increased prevalence of smaller and denser LDL particles in Asian Indians. Arterioscler Thromb Vasc Biol. 1999. 19:2749–2755.

22. Krauss RM. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol. 2005. 25:2265–2272.

23. Parks EJ, Hellerstein MK. Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am J Clin Nutr. 2000. 71:412–433.

24. Hyson DA, Mueller WM, Kasim-Karakas S. Impact of dietary fat intake on postprandial lipemic response in postmenopausal women. FASEB J. 1999. 13:A13.

25. Kasim-Karakas SE, Lane E, Almario R, Mueller W, Walzem R. Effects of dietary fat restriction on particle size of plasma lipoproteins in postmenopausal women. Metabolism. 1997. 46:431–436.

26. Campos H, Willett WC, Peterson RM, Siles X, Bailey SM, Wilson PW, Posner BM, Ordovas JM, Schaefer EJ. Nutrient intake comparisons between Framingham and rural and Urban Puriscal, Costa Rica. Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size. Arterioscler Thromb. 1991. 11:1089–1099.

27. Korea Centers for Disease Control and Prevention. The Third Korea National Health and Nutrition Examination Survey (KNHANES III). 2005. Seoul: Korea Centers for Disease Control and Prevention.

28. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M. Writing Group for The Partnership for Gender-Specific Medicine. Gender-specific care of the patient with diabetes: review and recommendations. Gend Med. 2006. 3:131–158.

29. Sarafidis PA, McFarlane SI, Bakris GL. Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome. Curr Diab Rep. 2006. 6:219–224.

30. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. San Antonio Heart Study. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004. 110:1251–1257.

31. Bentley-Lewis R, Koruda K, Seely EW. The metabolic syndrome in women. Nat Clin Pract Endocrinol Metab. 2007. 3:696–704.

32. Hwang IC, Kim KK, Suh DH, Lee KR. The cut off value of body fat percentage for diagnosing obesity among selected number of elementary school students in Seoul. Korean J Obes. 2008. 17:169–174.

33. Moon HK, Kong JE. Assessment of nutrient intake for middle aged with and without metabolic syndrome using 2005 and 2007 Korean National Health and Nutrition Survey. Korean J Nutr. 2010. 43:69–78.

34. Krauss RM. Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr. 2001. 131:340S–343S.

TOOLS

Similar articles